Loading…
CorMedix Inc. is projected to rise to $12.43 by 2027, a +48% move from its current price of $8.40. CRMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $8.20 | $8.41 | $8.62 | +0.07% |
| Jul 14 | $8.12 | $8.41 | $8.72 | +0.15% |
| Jul 15 | $8.06 | $8.42 | $8.79 | +0.22% |
| Jul 16 | $8.01 | $8.42 | $8.86 | +0.29% |
| Jul 17 | $7.97 | $8.43 | $8.92 | +0.37% |
| Jul 18 | $7.94 | $8.44 | $8.97 | +0.44% |
| Jul 19 | $7.90 | $8.44 | $9.02 | +0.51% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.90 | $8.44 | $9.02 | +0.51% |
| Week 2 | $7.73 | $8.49 | $9.32 | +1.03% |
| Week 3 | $7.61 | $8.53 | $9.57 | +1.55% |
| Week 4 | $7.51 | $8.57 | $9.79 | +2.07% |
| Week 5 | $7.43 | $8.62 | $9.99 | +2.60% |
| Week 6 | $7.37 | $8.66 | $10.19 | +3.12% |
| Week 7 | $7.31 | $8.71 | $10.37 | +3.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CorMedix Inc. is a Healthcare biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure.
CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
CorMedix Inc. (CRMD) is a healthcare stock currently trading at $8.47 with a market capitalization of $664.49M. It ranks 2854 by market cap. The stock’s current price sits near its near-term technical level, with a 30-day range of $7.05–$10.17.
Looking ahead, the forecasted path shows gradual upside: the 2026 average price is $8.47, with a 30-day window extending into higher values. The long-range view implies meaningful upside across the period, with the average price rising to $19.38 by 2030 and further to $136.43 by 2050, while the maximums reach $28.31 in 2030 and $253.83 in 2050.
A major floor 25.6% below — a decisive break under it would weaken the trend.
The nearest floor, 9.0% below — buyers have tended to step in here.
The nearest ceiling, 6.7% above — a clean break opens room to run.
A major ceiling 14.9% above — clearing it would confirm fresh momentum.
Key CRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.71 | Sell | $8.59 | Sell |
| MA 10 | $8.41 | Sell | $8.53 | Sell |
| MA 20 | $8.50 | Sell | $8.47 | Sell |
| MA 50 | $8.23 | Buy | $8.23 | Buy |
| MA 100 | $7.60 | Buy | $8.21 | Buy |
| MA 200 | $8.89 | Sell | $8.69 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.75 | Neutral |
| Stoch RSI (14) | 50.17 | Neutral |
| CCI (20) | -20.47 | Neutral |
| Williams %R (14) | -38.21 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.33 | Sell |
| Bollinger %B (20,2) | 0.44 | Neutral |
| Stochastic %K (14) | 61.79 | Neutral |
| TRIX (15) | 0.14 | Buy |
| Awesome (5,34) | 0.26 | Buy |
| Ultimate (7,14,28) | 59.32 | Neutral |
| Momentum (10) | 0.68 | Buy |
| Aroon Osc (25) | -44.00 | Sell |
| Hull MA (9) | 8.80 | Sell |
| ADX (14) | 16.71 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is bullish. RSI14 sits at 50, while the 50-day simple moving average is $8.08 and the 200-day simple moving average is $8.97. A price floor sits at $7.64 with resistance at $8.96, framing a 30-day range of $7.05–$10.17.
Annualized volatility stands around 50%, indicating substantial price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.25 | $8.40 | $12.18 | 0% | Neutral | |
| $9.97 | $12.43 | $16.34 | +48% | Bullish | |
| $11.19 | $14.31 | $19.47 | +70% | Bullish | |
| $12.84 | $16.76 | $23.43 | +100% | Bullish | |
| $14.01 | $18.63 | $26.64 | +122% | Bullish | |
| $15.32 | $20.72 | $30.22 | +147% | Bullish | |
| $18.60 | $25.55 | $37.93 | +204% | Bullish | |
| $22.40 | $31.22 | $47.10 | +272% | Bullish | |
| $26.08 | $36.86 | $56.44 | +339% | Bullish | |
| $27.42 | $39.27 | $60.97 | +367% | Bullish | |
| $46.08 | $70.06 | $115.27 | +734% | Bullish | |
| $77.36 | $130.25 | $233.30 | +14.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $6.25 | $8.40 | $10.34 | +0.00% |
| August 2026 | $7.57 | $8.92 | $10.77 | +6.15% |
| September 2026 | $7.58 | $8.98 | $10.96 | +0.71% |
| October 2026 | $7.86 | $9.37 | $11.53 | +4.32% |
| November 2026 | $8.16 | $9.77 | $12.11 | +4.31% |
| December 2026 | $8.12 | $9.76 | $12.18 | -0.09% |
Click any year to see its month-by-month CRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CRMD is projected to trade between $6.25 and $12.18, averaging $8.40 — a potential gain of 0% from today's $8.40. A consolidation phase looks the most probable path here.
CorMedix Inc.'s 2027 outlook centres on $12.43, within a $9.97 to $16.34 range. That is up +48% on the projected 2026 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2028, CRMD could reach as high as $19.47, with a base case around $14.31 and support toward $11.19 — roughly +70% from $8.40. Buyers look set to stay in control over this stretch.
Expect CRMD to range from $12.84 to $23.43 through 2029. The $16.76 average target implies a +100% move from current prices. That is up +17% on the projected 2028 average. Momentum favours further upside here.
The CRMD price prediction for 2030 points to an average of $18.63 (low $14.01, high $26.64) — a potential gain of +122% on today's $8.40. Buyers look set to stay in control over this stretch.
In 2031, CRMD is projected to trade between $15.32 and $30.22, averaging $20.72 — a potential gain of +147% from today's $8.40. That is up +11% on the projected 2030 average. Momentum favours further upside here.
CorMedix Inc.'s 2032 outlook centres on $25.55, within a $18.60 to $37.93 range. That is up +23% on the projected 2031 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CRMD could reach as high as $47.10, with a base case around $31.22 and support toward $22.40 — roughly +272% from $8.40. Momentum favours further upside here.
Expect CRMD to range from $26.08 to $56.44 through 2034. The $36.86 average target implies a +339% move from current prices. That is up +18% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CRMD price prediction for 2035 points to an average of $39.27 (low $27.42, high $60.97) — a potential gain of +367% on today's $8.40. Momentum favours further upside here.
In 2040, CRMD is projected to trade between $46.08 and $115.27, averaging $70.06 — a potential gain of +734% from today's $8.40. That is up +78% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CorMedix Inc.'s 2050 outlook centres on $130.25, within a $77.36 to $233.30 range. That is up +86% on the projected 2040 average. That marks a +14.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CRMD today (≈ 119.047619 CRMD) could be worth
$15,506.42
+$14,506.42 (+1451%) by 2050 · US Dollar
Based on the average projected CRMD price of $130.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRMDwould be worth at today's price.
$1,000 invested in CRMD on Jul 10, 2025 (≈ 85.397096 CRMD) would be worth
$717.34
-$282.66 (-28.3%) today · 0.72× · US Dollar
Based on a CRMD entry price of $11.71 vs. today's $8.4.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.75 | $960 | -4.0% |
| 1 month ago | $8.77 | $957.81 | -4.2% |
| 3 months ago | $7.24 | $1,160.22 | +16.0% |
| 6 months ago | $7.15 | $1,174.83 | +17.5% |
| 1 year ago | $11.71 | $717.34 | -28.3% |
| All time (5.0y) ago | $6.66 | $1,261.26 | +26.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRMD forecast.
Our base-case forecast reaches $17.00 around 2030.
Implied market cap at $17.00: $1.33B
The multi-year forecast shows persistent upside, with bullish sentiment advancing over time. The 2027 forecast calls for an average of $12.89 (min $10.24, max $17.19) and a ROI of 52.2. By 2028 the average is $14.75 (min $11.39, max $20.42) with a ROI of 74.2, and by 2029 the average is $17.15 (min $12.94, max $24.44) with a ROI of 102.5.
By 2030, the average rises to $19.38 (min $14.32, max $28.31) and the ROI is 128.8, with bullish sentiment continuing. The 2031–2035 trajectory shows ongoing gains, with 2031 average $21.24 (min $15.40, max $31.70) and 2032 average $26.55 (min $18.91, max $40.38), 2033 average $33.39 (min $23.38, max $51.67), 2034 average $38.81 (min $26.76, max $61.04), and 2035 average $40.96 (min $27.82, max $65.38).
The long-term horizon envisions substantial upside, with 2040 average $75.08 (min $47.61, max $127.55) and ROI of 786.4, followed by 2050 average $136.43 (min $76.88, max $253.83) and ROI of 1510.7, all with bullish sentiment. These figures are estimates and carry inherent uncertainty and risk, but they illustrate a potential for strong upside over the coming decades.
Tap a question to reveal the answer.
2030 forecast shows an average price of $19.38 with a min of $14.32 and a max of $28.31, and a ROI of 128.8, with a BULLISH sentiment.
The 2027–2050 forecasts indicate ongoing upside, with 2027 average $12.89 (ROI 52.2) through 2050 average $136.43 (ROI 1510.7) and bullish sentiment in the later years. These are estimates and not guarantees.
Yes. The forecast shows higher-end max values: 2034 max $61.04, 2035 max $65.38, 2040 max $127.55, and 2050 max $253.83, indicating $50 is within the projected upside.
Current price is $8.47 and market capitalization is $664.49M; the stock ranks 2854 by market cap.
The 30-day picture is bullish with RSI 50, SMA50 $8.08, SMA200 $8.97, support at $7.64, and resistance at $8.96. The 30-day range is $7.05–$10.17, and annualized volatility is 50%.
CorMedix Inc. Community Discussion
0Share your CorMedix Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.